Broadfin Capital, LLC - AEGERION PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Broadfin Capital, LLC ownership history of AEGERION PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$12,953,000
+116.8%
4,361,291
+8.8%
1.16%
+99.8%
Q2 2016$5,975,000
-59.7%
4,010,2910.0%0.58%
-59.5%
Q1 2016$14,838,000
-63.4%
4,010,2910.0%1.43%
-42.5%
Q4 2015$40,504,000
+28.4%
4,010,291
+72.8%
2.49%
+41.9%
Q3 2015$31,557,000
-41.7%
2,320,366
-18.7%
1.76%
-39.6%
Q2 2015$54,113,000
-19.0%
2,852,578
+11.8%
2.91%
-44.1%
Q1 2015$66,801,000
-40.9%
2,552,578
-52.7%
5.20%
+5.9%
Q4 2014$113,028,000
+236.4%
5,397,726
+436.3%
4.91%
+39.5%
Q3 2014$33,599,000
-35.4%
1,006,562
-37.9%
3.52%
+37.7%
Q2 2014$51,988,000
+221.6%
1,620,088
+362.9%
2.56%
+63.3%
Q1 2014$16,163,000350,0001.57%
Other shareholders

There were no reported owners of AEGERION PHARMACEUTICALS INC in Q4 2016.

NameSharesValueWeighting ↓
View complete list of AEGERION PHARMACEUTICALS INC shareholders